Clinical Perspectives on New Data in Advanced NSCLC

EP. 1: Locally Advanced NSCLC: Approaching the PACIFIC Trial

October 15th 2018

EP. 2: Global Perspectives on the PACIFIC Trial in NSCLC

October 15th 2018

EP. 3: Appropriate Settings for the PACIFIC Regimen in NSCLC

October 15th 2018

EP. 4: Advanced-Stage NSCLC: KEYNOTE-189's Role in Treatment

October 15th 2018

EP. 5: Personal Use of I-O Therapy in Advanced-Stage NSCLC

October 15th 2018

EP. 6: Treatment After Progression in Advanced-Stage NSCLC

October 15th 2018

EP. 7: CheckMate 227: TMB Versus PD-L1 in Advanced-Stage NSCLC

October 15th 2018

EP. 8: Managing Oligometastases With Ablative Therapy in NSCLC

October 15th 2018

EP. 9: Osimertinib's Role in EGFR+ Metastatic Lung Cancer

October 15th 2018

EP. 10: Global Perspectives on Use of Osimertinib in EGFR+ NSCLC

October 15th 2018

EP. 11: Changing the Treatment Paradigm for ALK-Rearranged NSCLC

October 15th 2018

EP. 12: Sequencing Therapies in ALK-Rearranged NSCLC

October 15th 2018

EP. 13: Considering Targeted Agents in BRAF-Mutant NSCLC

October 15th 2018

EP. 14: Other Targeted Approaches in NSCLC: NTRK or RET Fusions

October 15th 2018

EP. 15: Take-Home Messages on the NSCLC Treatment Paradigm

October 15th 2018